These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 15202175)
21. Stanford to ban drug makers' gifts to doctors, even pens. Pollack A N Y Times Web; 2006 Sep; ():C2. PubMed ID: 16972375 [No Abstract] [Full Text] [Related]
22. The details are in the field. Schwab AP Am J Bioeth; 2010 Jan; 10(1):19-21. PubMed ID: 20077330 [No Abstract] [Full Text] [Related]
23. New developments in managing physician-industry relationships. Rothman DJ; Chimonas S JAMA; 2008 Sep; 300(9):1067-9. PubMed ID: 18768417 [No Abstract] [Full Text] [Related]
24. Large or small, a gift is a gift is a gift. Paris JJ Am J Bioeth; 2003; 3(3):W30. PubMed ID: 14594482 [No Abstract] [Full Text] [Related]
25. The AAMC exhibits the behavior it condemns. Stossel TP Am J Bioeth; 2010 Jan; 10(1):26-7. PubMed ID: 20077333 [No Abstract] [Full Text] [Related]
26. Drug detailers, professionalism, and prudence. Brody H Am J Bioeth; 2010 Jan; 10(1):9-10. PubMed ID: 20077325 [No Abstract] [Full Text] [Related]
27. The high cost of free lunch. Rankin RC Obstet Gynecol; 2007 Oct; 110(4):932. PubMed ID: 17906040 [No Abstract] [Full Text] [Related]
28. The high cost of free lunch. Randall DA Obstet Gynecol; 2007 Oct; 110(4):932; author reply 932-3. PubMed ID: 17906039 [No Abstract] [Full Text] [Related]
29. The high cost of free lunch. Frohlich EP Obstet Gynecol; 2007 Oct; 110(4):931; author reply 932-3. PubMed ID: 17906038 [No Abstract] [Full Text] [Related]
30. The high cost of free lunch. Campbell WA Obstet Gynecol; 2007 Oct; 110(4):931-2; author reply 932-3. PubMed ID: 17906037 [No Abstract] [Full Text] [Related]
31. The devil in the detail(ing). Morreim H Am J Bioeth; 2010 Jan; 10(1):15-7. PubMed ID: 20077328 [No Abstract] [Full Text] [Related]
32. Pharmaceutical gift giving: analysis of an ethical dilemma. Stokamer CL J Nurs Adm; 2003 Jan; 33(1):48-51. PubMed ID: 12544625 [TBL] [Abstract][Full Text] [Related]
33. The pitfalls of misreading: what does "industry funding of medical education" actually say? Spielman B Am J Bioeth; 2010 Jan; 10(1):24-5. PubMed ID: 20077332 [No Abstract] [Full Text] [Related]
34. Drug makers pay for lunch as they pitch. Saul S N Y Times Web; 2006 Jul; ():A1, C7. PubMed ID: 16909492 [No Abstract] [Full Text] [Related]
35. Curbing the influence of the drug industry: a British view. Smith R PLoS Med; 2005 Sep; 2(9):e241. PubMed ID: 16076242 [TBL] [Abstract][Full Text] [Related]
36. Reforming pharmaceutical industry-physician financial relationships: lessons from the United States, France, and Japan. Rodwin MA J Law Med Ethics; 2011; 39(4):662-70. PubMed ID: 22084852 [TBL] [Abstract][Full Text] [Related]
37. Avoiding over-deterrence in managing physicians' relationships with industry. Stell LK Am J Bioeth; 2010 Jan; 10(1):27-9. PubMed ID: 20077334 [No Abstract] [Full Text] [Related]
38. Huddle gets it right, most docs don't. Rubin PH Am J Bioeth; 2010 Jan; 10(1):17-9. PubMed ID: 20077329 [No Abstract] [Full Text] [Related]
39. Contact with pharmaceutical representatives: where does prudence lead? Appelbaum PS Am J Bioeth; 2010 Jan; 10(1):11-3. PubMed ID: 20077326 [No Abstract] [Full Text] [Related]
40. Should a medical practice accept a gift with strings attached? Agrawal M; Steinberg D Med Ethics (Burlingt Mass); 2001; ():3, 7. PubMed ID: 15584189 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]